📊 Explore the dynamic landscape of immune-mediated therapies and stay at the forefront of groundbreaking developments. Download your copy now: ter.li/nzqbyr?utm_campaign=m…

🔍 Curious about the gene therapy landscape in 2023? 🌱 Explore part 2 of our 2023 Landscape Series for an in-depth analysis of trial changes in 2023, terminations and regulatory announcements. Download now! ter.li/2y5o6l?utm_campaign=m… #GeneTherapyInsights #2023Analysis #2023Review

📈 Keep your finger on the pulse of gene therapy innovations! 💡 The Annual 2023 Landscape Review is out now, offering a comprehensive look at the latest changes. Download Part 1 of the series and stay informed! ter.li/2y5o6l?utm_campaign=m… #GeneTherapyInnovation #2023Review

The first part of our 2023 Immune Tolerance Landscape Review is available for download. 📊 Stay informed on the latest immune-mediated therapies – assets, mechanisms, and more. Your key to staying ahead is expanding the field rapidly. Get your copy: ter.li/nzqbyr?utm_campaign=m…

🔓 Unlock exciting insights from ESMO 2023! Our Post-Conference Report summarizes the 41 cytokine-related abstracts presented. Find out how new developments are transforming treatments for solid tumors, lung cancer, and more! Download your copy: ter.li/3dkblq?utm_campaign=m… #ESMO

🧪The Checkpoint Disease Landscape delves into the dynamic world of ICMs and centers on the top 5 oncology disease indications across drugs and trials. This Report is your essential guide to the future of checkpoint therapies. Download here: ter.li/6lyc64?utm_campaign=m… #Oncology

🔎 Curious about the exciting insights shared at ESMO? Dive into our Post-Conference Report to explore the top drug assets, trial phases, and disease indications, plus a summary of all 333 abstracts presented at the event. Download the report today! ter.li/1smj6b?utm_campaign=m… #ESMO

Our brand new report, The Preclinical Cytokine Review provides crucial insights into: 🎯 Top Targets including IL-2, IL-15, and IL-12 🔬 Disease Indications 🐭 Preclinical Models 📣 IND Approvals Download here: ter.li/7r8y3t?utm_campaign=m… #Cytokines #DrugDevelopment #PreclinicalData

📈 Of the 804 ADCs currently in preclinical development, 71% are classed as active, showing evidence of continued development and instilling confidence for the future. Discover top targets, moiety formats and more in our infographic: ter.li/1fd2ac?utm_campaign=m… #Preclinical #ADCs

💊The preclinical ADC landscape is experiencing impressive growth but the is also facing a shift as popular target HER-2 begins to decline and two promising targets climb the ranks. Download our infographic to reveal top targets and more… ter.li/1fd2ac?utm_campaign=m… #ADCs #HER2

Empower your drug development with Beacon Cell Therapy. Our comprehensive database of +5800 drugs and +4700 trials provides accurate, timely, and exhaustive data for informed decision-making. #DataDrivenSolutions #CellTherapies ter.li/npw4n5?utm_campaign=m…

📗 The Cancer Vaccine ASCO Post-Conference Report 2023 is here to download ter.li/as8mjg?utm_campaign=m…. Access detailed insights on the abstract analysis broken down by data type, therapeutic class, and trial phase, also clinical, trial outline, and preclinical abstract summaries.

📗 The OV ASCO Post-Conference Report 2023 is here to download ter.li/tc056k?utm_campaign=m…. Access detailed insights on the abstract analysis broken down by data type, viral family, and clinical abstract properties also clinical, trial outline, and preclinical abstract summaries.

📈 The number of cytokine-armored cell therapy trials has accelerated since 2019 and the field shows huge potential! Our report highlights the top 10 cytokine-armoring strategies, trends in recent trials and more! Download the report here: ter.li/cy4ac1?utm_campaign=m… #celltherapies

Cytokine-armored cell therapies are climbing in popularity! With trials increasing year-on-year since 2019, it is imperative to stay informed on this emerging landscape. 📥 Download the free report for expert analysis: ter.li/cy4ac1?utm_campaign=m… #celltherapies #drugdevelopment

🚨Cancer Vaccine AACR Post-Conference Report Released ter.li/mfc2de View the in-depth analysis of 54 cancer vaccine-relevant abstracts, including 26 clinical and 28 preclinical. #aacr23 #cancervaccine #report

🚨Adoptive Cell AACR Post-Conference Report Released ter.li/lsx7at🚨 View the in-depth analysis of 107 adoptive cell-relevant abstracts, including 21 clinical and 86 preclinical. #aacr2023 #adoptivecell #REPORT

🚨Oncolytic Viruses AACR Post-Conference Report Released ter.li/tc6e5g🚨 View the in-depth analysis of 39 oncolytic viruses-relevant abstracts, including 13 clinical and 26 preclinical. #aacr23 #oncology #report

Our latest infographic on the hot topic Neoantigen Cancer Vaccines is free to download here ter.li/v0xm94 Find out more by downloading the infographic. #cancervaccine #infographic #neoantigen

📢 The AACR 2023 Annual Meeting begins tomorrow! Prepare your schedule using our Cytokine Pre-Conference Planner that lists 149 abstracts. View the Planner here: ter.li/h79pd?utm_campaign=me… #cytokine #AACR #AACR2023 #drugdevelopment